Cargando…

Vitamin D and Autism Spectrum Disorder: A Literature Review

Low vitamin D status in early development has been hypothesised as an environmental risk factor for Autism Spectrum Disorder (ASD), given the concurrent increase in the prevalence of these two conditions, and the association of vitamin D with many ASD-associated medical conditions. Identification of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazahery, Hajar, Camargo, Carlos A., Conlon, Cathryn, Beck, Kathryn L., Kruger, Marlena C., von Hurst, Pamela R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848704/
https://www.ncbi.nlm.nih.gov/pubmed/27110819
http://dx.doi.org/10.3390/nu8040236
_version_ 1782429400967413760
author Mazahery, Hajar
Camargo, Carlos A.
Conlon, Cathryn
Beck, Kathryn L.
Kruger, Marlena C.
von Hurst, Pamela R.
author_facet Mazahery, Hajar
Camargo, Carlos A.
Conlon, Cathryn
Beck, Kathryn L.
Kruger, Marlena C.
von Hurst, Pamela R.
author_sort Mazahery, Hajar
collection PubMed
description Low vitamin D status in early development has been hypothesised as an environmental risk factor for Autism Spectrum Disorder (ASD), given the concurrent increase in the prevalence of these two conditions, and the association of vitamin D with many ASD-associated medical conditions. Identification of vitamin D-ASD factors may provide indications for primary and secondary prevention interventions. We systematically reviewed the literature for studies on vitamin D-ASD relationship, including potential mechanistic pathways. We identified seven specific areas, including: latitude, season of conception/birth, maternal migration/ethnicity, vitamin D status of mothers and ASD patients, and vitamin D intervention to prevent and treat ASD. Due to differences in the methodological procedures and inconsistent results, drawing conclusions from the first three areas is difficult. Using a more direct measure of vitamin D status—that is, serum 25(OH)D level during pregnancy or childhood—we found growing evidence for a relationship between vitamin D and ASD. These findings are supported by convincing evidence from experimental studies investigating the mechanistic pathways. However, with few primary and secondary prevention intervention trials, this relationship cannot be determined, unless randomised placebo-controlled trials of vitamin D as a preventive or disease-modifying measure in ASD patients are available.
format Online
Article
Text
id pubmed-4848704
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-48487042016-05-04 Vitamin D and Autism Spectrum Disorder: A Literature Review Mazahery, Hajar Camargo, Carlos A. Conlon, Cathryn Beck, Kathryn L. Kruger, Marlena C. von Hurst, Pamela R. Nutrients Review Low vitamin D status in early development has been hypothesised as an environmental risk factor for Autism Spectrum Disorder (ASD), given the concurrent increase in the prevalence of these two conditions, and the association of vitamin D with many ASD-associated medical conditions. Identification of vitamin D-ASD factors may provide indications for primary and secondary prevention interventions. We systematically reviewed the literature for studies on vitamin D-ASD relationship, including potential mechanistic pathways. We identified seven specific areas, including: latitude, season of conception/birth, maternal migration/ethnicity, vitamin D status of mothers and ASD patients, and vitamin D intervention to prevent and treat ASD. Due to differences in the methodological procedures and inconsistent results, drawing conclusions from the first three areas is difficult. Using a more direct measure of vitamin D status—that is, serum 25(OH)D level during pregnancy or childhood—we found growing evidence for a relationship between vitamin D and ASD. These findings are supported by convincing evidence from experimental studies investigating the mechanistic pathways. However, with few primary and secondary prevention intervention trials, this relationship cannot be determined, unless randomised placebo-controlled trials of vitamin D as a preventive or disease-modifying measure in ASD patients are available. MDPI 2016-04-21 /pmc/articles/PMC4848704/ /pubmed/27110819 http://dx.doi.org/10.3390/nu8040236 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mazahery, Hajar
Camargo, Carlos A.
Conlon, Cathryn
Beck, Kathryn L.
Kruger, Marlena C.
von Hurst, Pamela R.
Vitamin D and Autism Spectrum Disorder: A Literature Review
title Vitamin D and Autism Spectrum Disorder: A Literature Review
title_full Vitamin D and Autism Spectrum Disorder: A Literature Review
title_fullStr Vitamin D and Autism Spectrum Disorder: A Literature Review
title_full_unstemmed Vitamin D and Autism Spectrum Disorder: A Literature Review
title_short Vitamin D and Autism Spectrum Disorder: A Literature Review
title_sort vitamin d and autism spectrum disorder: a literature review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848704/
https://www.ncbi.nlm.nih.gov/pubmed/27110819
http://dx.doi.org/10.3390/nu8040236
work_keys_str_mv AT mazaheryhajar vitamindandautismspectrumdisorderaliteraturereview
AT camargocarlosa vitamindandautismspectrumdisorderaliteraturereview
AT conloncathryn vitamindandautismspectrumdisorderaliteraturereview
AT beckkathrynl vitamindandautismspectrumdisorderaliteraturereview
AT krugermarlenac vitamindandautismspectrumdisorderaliteraturereview
AT vonhurstpamelar vitamindandautismspectrumdisorderaliteraturereview